|
Index of reports
> Cases resulting in hospitalization (16)
> Cases with Sepsis (3)
Below is the selection of adverse event reports related to Diflucan (Fluconazole) that includes cases resulting in hospitalization where reactions include sepsis.
Adverse event in 3 year old female receiving Diflucan (Fluconazole)
Reported by a individual with unspecified qualification from United States on 2007-10-23
Patient: 3 year old female, weighing 22.7 kg (49.9 pounds)
Adverse reactions / side effects: Dermatitis Allergic, LIP Swelling, Skin Chapped, Aspiration Bone Marrow Abnormal, Skin Exfoliation, Urticaria, Respiratory Syncytial Virus Infection, Helicobacter Sepsis, Auricular Swelling, Blood Pressure Inadequately Controlled, Bacterial Sepsis, Skin Haemorrhage, Angioedema, Swelling Face, Drug Hypersensitivity, Staphylococcal Sepsis, Sepsis, Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Amlodipine Besylate
Dosage: daily;oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-04-01
Amlodipine Besylate
Dosage: daily;oral
Administration route: Oral
Indication: Secondary Hypertension
Start date: 2004-04-01
Diflucan
Dosage: oral
Administration route: Oral
Indication: Fungal Infection
Start date: 2007-08-29
End date: 2007-09-25
Enalapril Maleate
Indication: Hypertension
Start date: 2004-05-01
End date: 2006-06-01
Enalapril Maleate
Indication: Secondary Hypertension
Start date: 2004-05-01
End date: 2006-06-01
Enalapril Maleate
Indication: Hypertension
Start date: 2007-09-07
End date: 2007-10-02
Enalapril Maleate
Indication: Secondary Hypertension
Start date: 2007-09-07
End date: 2007-10-02
Enalapril Maleate
Dosage: daily;oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-05-01
End date: 2006-06-01
Enalapril Maleate
Dosage: daily;oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-09-07
End date: 2007-10-02
Prevacid
Start date: 2004-01-01
End date: 2006-06-01
Other drugs received by patient: Prednisolone; Cyclosporine; Cozaar
Adverse event in 3 year old female receiving Diflucan (Fluconazole)
Reported by a individual with unspecified qualification from United States on 2007-10-12
Patient: 3 year old female, weighing 22.7 kg (49.9 pounds)
Adverse reactions / side effects: LIP Swelling, Dermatitis Allergic, Graft Versus Host Disease, Skin Exfoliation, Urticaria, Skin Fissures, Respiratory Syncytial Virus Infection, Helicobacter Sepsis, Dermatitis Contact, Bone Marrow Disorder, Auricular Swelling, Blood Pressure Inadequately Controlled, Bacterial Infection, Bacterial Sepsis, Skin Haemorrhage, Swelling Face, Dermatitis Atopic, Drug Hypersensitivity, Ill-Defined Disorder, Staphylococcal Sepsis, Bacteraemia, Sepsis, NO Therapeutic Response, Neutropenia, Inflammation
Adverse event resulted in: hospitalization
Suspect drug(s):
Amlodipine
Dosage: oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-04-30
End date: 2007-10-02
Diflucan
Dosage: oral
Administration route: Oral
Indication: Fungal Infection
Start date: 2007-08-29
End date: 2007-09-25
Enalapril Maleate
Dosage: 1 tablet, daily, oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-04-30
End date: 2006-06-01
Enalapril Maleate
Dosage: 1 tablet, daily, oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-09-07
End date: 2007-10-02
Enalapril Maleate
Dosage: 1 tablet , daily, (alt w/ watson),oral
Administration route: Oral
Indication: Hypertension
Start date: 2004-04-30
End date: 2006-06-01
Enalapril Maleate
Dosage: 1 tablet , daily, (alt w/ watson),oral
Administration route: Oral
Indication: Hypertension
Start date: 2007-09-07
End date: 2007-10-02
Prevacid
Start date: 2004-01-01
End date: 2006-06-01
Other drugs received by patient: Prednisolone; Closporine (Ciclosporin)
Adverse event in 29 year old male receiving Diflucan (Fluconazole)
Reported by a physician from Japan on 2007-10-02
Patient: 29 year old male
Adverse reactions / side effects: Metabolic Acidosis, Diabetes Mellitus, Rash, Renal Impairment, Renal Failure, Respiratory Failure, Diarrhoea, Respiratory Acidosis, Sepsis, Renal Tubular Necrosis, Clostridial Infection
Adverse event resulted in: hospitalization
Suspect drug(s):
Baktar
Administration route: Oral
Indication: Pneumocystis Jiroveci Pneumonia
Start date: 2001-05-19
End date: 2001-05-22
Carbenin
Indication: Pneumonia Bacterial
Start date: 2001-05-28
End date: 2001-06-15
Denosine
Indication: Pneumonia Bacterial
Start date: 2001-05-19
End date: 2001-06-01
Diflucan
Indication: Pneumonia Bacterial
Start date: 2001-05-19
End date: 2001-06-12
Diprivan
Indication: Sedation
Start date: 2001-05-19
End date: 2001-06-03
Dopamine Hydrochloride
Indication: Blood Pressure Increased
Start date: 2001-05-19
End date: 2001-05-31
Erythromycin
Administration route: Oral
Indication: Pneumonia Bacterial
End date: 2001-05-19
Ethambutol Hydrochloride
Administration route: Oral
Indication: Pneumonia Bacterial
End date: 2001-05-21
Firstcin
Indication: Pneumonia
Start date: 2001-05-19
End date: 2001-05-28
FOY
Indication: Disseminated Intravascular Coagulation
Start date: 2001-05-19
End date: 2001-05-31
Futhan
Indication: Extracorporeal Circulation
Start date: 2001-05-19
End date: 2001-05-27
Iscotin
Administration route: Oral
Indication: Pneumonia Bacterial
Start date: 2001-05-19
End date: 2001-06-07
Lasix
Indication: Polyuria
Start date: 2001-05-19
End date: 2001-06-04
Primaxin
Indication: Pneumonia Bacterial
Start date: 2001-05-17
End date: 2001-05-19
Solu-Medrol
Indication: Pneumonia
Start date: 2001-05-19
End date: 2001-05-21
Venoglobulin
Indication: Pneumonia Bacterial
Start date: 2001-05-20
End date: 2001-05-22
|
